Four UK innovators selected to transform patient flow through 5G-enabled healthcare solutions
CPI’s 5G innovation programme to accelerate digital solutions in healthcare has now selected four companies to receive tailored support from CPI.
Sept 04 2025
News
CPI and Quotient Sciences to accelerate RNA drug development with joint venture
CPI and Quotient Sciences have signed an MoU to form a joint venture aimed at accelerating the development of RNA-based therapies.
Sept 02 2025
News
Government-backed UKRNA Biofoundry to turbo-charge next-gen therapies through CPI’s RNA Centre of Excellence
Backed by £29.6m government funding, the UKRNA Biofoundry will drive new RNA therapies – helping tackle cancer, heart conditions, and other diseases.
Aug 28 2025
News
New partnership to advance RNA vaccines for livestock
CPI and CVIM sign MoU to boost veterinary vaccine development, starting with cutting-edge RNA vaccine technologies at The Pirbright Institute.
Aug 06 2025
News
CPI joins consortium to deliver a first-of-a-kind EV Li-ion battery chemical demonstrator plant
UK consortium led by FluoRok to build first LiPF₆ plant for EV batteries, boosting UK lithium-ion supply chain and manufacturing resilience.
Aug 04 2025
News
UK diagnostics innovator secures investment to advance pharmaceutical testing
Cotton Mouton Diagnostics (CMD), a UK-based diagnostics company, has secured £500,000 from CPI Enterprises via the Innovate UK Catapult Investment Pilot.
Jul 29 2025
Blog
Overcoming intracellular drug delivery barriers with LNP technology
Explore how LNP innovations are overcoming delivery barriers to unlock the full potential of mRNA and gene-editing therapies.
Jul 25 2025
Blog
Navigating drug delivery systems: Key considerations and new approaches
Delivering next-gen therapeutics like RNA and proteins means mastering the science and scale-up of complex nanoparticle systems.
The international initiative brings together leading organisations to transform biologics and drug manufacture through AI-driven multiplatform integration.
